Ignite Creation Date:
2025-12-24 @ 9:16 PM
Ignite Modification Date:
2025-12-30 @ 12:51 AM
Study NCT ID:
NCT00894504
Status:
COMPLETED
Last Update Posted:
2015-05-15
First Post:
2009-05-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer
Sponsor:
SCRI Development Innovations, LLC
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
SCRI BRE 126
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None